How Bone Metastasis Impacts NSCLC Outcomes With Immune Checkpoint Inhibitors | Docwire News
The retrospective analysis reaffirmed evidence from CCTG BR.34 that showed bone metastasis was associated with worse outcomes in ICI-treated NSCLC, with or without chemotherapy.